Codes ATC:
P02CA03
EMLc
Indication
Cysticercosis of central nervous system
Code ICD11:
1F70.0
INN
Albendazole
Type de médicament
Chemical agent
Type de liste
Liste complémentaire
(EML)
(EMLc)
(EMLc)
Formulations
Oral > Solid > tablet:
400 mg (chewable, scored) ;
200 mg (chewable)
(EMLc)
Historique des statuts LME
Sexe
Tous
Âge
Aussi recommandé pour les enfants
Équivalence thérapeutique
La recommandation concerne ce médicament spécifique
Renseignements sur le brevet
Patents have expired in most jurisdictions
Lire la suite
sur les brevets.
Wikipédia
DrugBank
Résumé des preuves et recommandation du comité d'experts
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended the listings for albendazole 400 mg chewable tablets on the EML and EMLc be amended to specify that they be scored.
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended the the addition of a new strength formulation (200 mg chewable tablets) to the EMLc for treatment of diseases caused by taeniid cestode cysts.